Application of Behavioral Economics to Life Science Market Research

An Opinion Piece

Author: Alistair Ellmer, Research Director, Beacon Consulting

The use of behavioral economic principles as a tool to explain decision-making in consumer market research is well established, yet almost unheard of in the life sciences. Alistair Ellmer, Research Director at Beacon Consulting, explores why this is, and why this is bad for business.

Application of Behavioral Economics to Life Science Market Research

Whatever your opinion on behavioral economics, it’s hard to escape. It is the subject of several best sellers (‘Freakonomics’, by Steven Levitt and Stephen Dubner; ‘Thinking, Fast and Slow’ by Nobel Prize winner Daniel Kahneman) and some of its principles have even entered the general lexicon (e.g. ‘game theory’, ‘loss aversion’).

As a theory on human conduct, it rests on the observation that people often make illogical decisions. Homo economicus, a being that behaves with perfect rationality and self-interest, is not real. Many factors drive irrational behavior – these may be psychological, cognitive, emotional, cultural, or social, and work at conscious or subconscious level.

As someone professionally invested in understanding not just how people behave but why, I find this subject fascinating. In particular, this idea that we believe we are more rational than we are in reality. This speaks to one of the main challenges of drawing meaningful insights from market research – if customers cannot recognize the true drivers of their own behavior, how are marketeers, strategists and sales teams meant to know?

This gap between stated and actual behavior is well accounted for in the retail sector, with experts available to apply key principles to explain everything from purchasing life insurance to cereal. Now you could argue that while ‘Joe Public’ is susceptible to emotional thinking, life science professionals are ‘built differently’. They are trained to make conclusions based on objective analysis of data. But I would say that belief is somewhat naïve and refer you to a different sector with scientifically-minded consumers – healthcare professionals.

I have been on the receiving end of many a lecture from doctors emphasizing the importance of facts and taking emotion out of the equation. Yet, in the same interview, they tell me they prefer treatments with which they feel comfortable, even if data suggests a newer alternative is superior. A perfect example of irrational behavior dictating decisions, in this case likely driven by familiarity bias. By using this knowledge, pharma companies are also leveraging behavior triggers to optimize brand success.

What does this mean for market research with life science professionals? First, we need to acknowledge that life scientists, like physicians, like you and me, are only human, and just as subject to the same biases and influential factors. Next, we need to execute research appropriately. Hanson Wade Intelligence combine highly scientific technical knowledge with clever questioning and techniques that truly get ‘underneath the skin’ of your customers. Finally, content must be analyzed via this lens, to deliver a deep understanding of not just what is said, but what it means.

We have had great success approaching research with this mindset, revealing new insights in a space our client thought they knew all there was to know. This allowed them to revitalize their communication materials to increase resonance and land more effectively.

One final thought – many clients are frustrated because customers are not acting as desired, and they feel powerless to change it. If this frustration feels familiar, then let Hanson Wade Intelligence show you how the utilization of behavioral economic principles could make the difference.

Learn More About Consulting

What is Beacon Consulting?
  • We are specialist life sciences market research and consultants, delivering tailored insights across the full drug development and commercialisation lifecycle.
  • Combines scientific expertise, expert networks, and proprietary Beacon data to transform complex data into clear, strategic decisions.
  • Provides fully customised research, spanning qualitative interviews, quantitative analysis, and desk research, aligned to your specific business objectives.
  • Helps biopharma teams reduce risk, identify opportunities, and accelerate decision-making with actionable, decision-ready insights.
Learn More About Beacon Consulting

What is Beacon?

Beacon is the essential intelligence platform for R&D decision-makers working in pharma and biotech, offering unique technology and drug datasets for complex therapeutics and disease areas.

Our market-defining proprietary ontologies, manual data curation, and accurate and comprehensive life science data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.

This is why 24 of the top 25 pharmaceutical companies trust Beacon to power their critical pipeline, competitive, and commercial decisions.

We’d welcome the opportunity to show you how Beacon can transform your data strategy. Book your personalized demonstration today!

Request Demonstration

Menu
Search Icon
Close Icon
Search